Doctor charged for drug diversion at Columbia County hospital
Dr. Richard Hubbell denies the charges; a preliminary hearing is scheduled next month
Stay updated with breaking news from Benjamin Stanton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Richard Hubbell denies the charges; a preliminary hearing is scheduled next month
In a paper published in NAR Cancer, researchers from the Center for Childhood Cancer Research at Nationwide Children's and their collaborators report a comprehensive 3D chromatin structural analysis and characterization of rhabdomyosarcoma (RMS). RMS is a pediatric soft-tissue tumor that predominantly affects children between 0 and 4 years, but it can also affect adolescents. Survival rates vary dramatically from 10% to 90% depending on the stage and subtype.
A Hanover Twp. man snared in an online sex sting was sentenced Thursday to serve up to five years in state prison after claiming he had only been “messing” with
MFCR awards new grants to support an emerging approach to cancer therapeutics The Mark Foundation for Cancer Research (MFCR) has awarded five new grants in support of an important, emerging approach to cancer therapeutics. The projects are centered around the molecular strategy of induced proximity, which involves controlling the physical distance between proteins to regulate or perturb biological processes in the cancer cell. One of the biggest challenges in developing new cancer therapies is that many proteins are not tractable to the traditional approach in drug discovery of directly inhib...
E-Mail NEW YORK - The Mark Foundation for Cancer Research (MFCR) has awarded five new grants in support of an important, emerging approach to cancer therapeutics. The projects are centered around the molecular strategy of induced proximity, which involves controlling the physical distance between proteins to regulate or perturb biological processes in the cancer cell. One of the biggest challenges in developing new cancer therapies is that many proteins are not tractable to the traditional approach in drug discovery of directly inhibiting the function of a therapeutic target. The induced p...